雲頂香港(00678.HK)擬提交臨時清盤呈請 1月18日起停牌
格隆匯1月18日丨雲頂香港(00678.HK)發佈公吿,史亞倫、林懷漢及陳和瑜已辭去獨立非執行董事的職務,據此不再擔任公司審核委員會、薪酬委員會及提名委員會(如適用)的成員,上述各項均於2022年1月18日起生效。
鑑於集團的財務狀況,除非公司收到一項可行建議,其中附帶一個令公司能夠償還到期債務、各方一致認可及同時滿足各方條件的重組方案,否則董事會將有可能擬於2022年1月18日(百慕達時間)向百慕達主管法院提交公司的臨時清盤呈請。公司已向聯交所申請自2022年1月18日(星期二)上午九時正起暫停股份買賣,直至另行通知。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.